ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 72 filers reported holding ARALEZ PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $5,325,000 | -45.0% | 2,488,475 | +13.3% | 0.33% | -50.2% |
| Q4 2016 | $9,685,000 | -6.7% | 2,196,055 | +2.6% | 0.65% | -4.4% |
| Q3 2016 | $10,384,000 | +107.7% | 2,141,051 | +41.3% | 0.68% | +92.1% |
| Q2 2016 | $4,999,000 | +1.1% | 1,514,918 | +8.8% | 0.36% | -2.7% |
| Q1 2016 | $4,944,000 | – | 1,392,746 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management, LLC | 237,547 | $843,000 | 13.09% |
| JW Asset Management, LLC | 1,836,375 | $6,519,000 | 4.26% |
| DRILL CRAIG A | 339,300 | $1,205,000 | 3.04% |
| Tiger Legatus Capital Management, LLC | 1,275,000 | $4,526,000 | 1.80% |
| Broadfin Capital, LLC | 3,800,000 | $13,490,000 | 1.30% |
| Healthcare Value Capital, LLC | 175,000 | $621,000 | 0.91% |
| Kavi Asset Management, LP | 313,627 | $1,113,000 | 0.87% |
| Healthcare Value Capital, LLC | 100,000 | $355,000 | 0.52% |
| Elk Creek Partners, LLC | 1,392,746 | $4,944,000 | 0.37% |
| Par Capital Management | 5,365,000 | $19,046,000 | 0.30% |